Research Article
Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer
Figure 4
Distribution of CD45+CD14+ MO/MA in the (a) malignant and (b) nonmalignant ovarian tumor microenvironment.
(a) |
(b) |